Is Wegovy on the PBS? (2026 Guide)

No — Wegovy is not on the PBS in Australia as at 2026. Every Wegovy script for weight management is a private prescription, which means you pay the full pharmacy price of roughly $180–$320 per month depending on dose, rather than a PBS co-payment of around $31.60. This guide covers why, whether that's likely to change, and what you can do to keep the total cost of treatment down in the meantime.

The short answer at a glance

• Is Wegovy PBS-subsidised? No — not for weight management, at any dose.
• What do you pay instead? The private pharmacy price: roughly $180–$320/month by dose.
• Is any weight loss medication on the PBS? No — none are currently subsidised when prescribed for weight management.
• What can be $0? The GP care around the medication — assessment, prescribing and follow-ups can be bulk billed through Medicare.

Why isn't Wegovy on the PBS?

PBS listing is decided by the Pharmaceutical Benefits Advisory Committee (PBAC), which weighs a medicine's clinical benefit against its cost to taxpayers at population scale. Wegovy's clinical evidence is strong — semaglutide 2.4mg produces roughly 15% average body-weight loss in trials — but the potential patient population in Australia is enormous, and at current pricing the total cost to the Commonwealth would be one of the largest line items on the entire scheme.

Novo Nordisk has pursued listing, and PBAC has considered obesity medications more than once. The sticking point has consistently been cost-effectiveness at scale, not whether the medication works. Until that equation changes — through price negotiation, restricted eligibility criteria, or both — Wegovy remains a private script.

What Wegovy actually costs without the PBS

Private pricing varies by dose and pharmacy. As a guide, Australian patients currently pay roughly $180 a month at the lower maintenance doses, rising towards $320 a month at the full 2.4mg dose. Our dose-by-dose Wegovy price guide tracks current pharmacy pricing in detail, and our broader Wegovy cost guide covers the full picture including how dose titration affects your monthly spend.

Will Wegovy be PBS-listed in the future?

Momentum is genuinely building. Obesity is formally recognised as a chronic disease by Australian clinical bodies, the evidence that effective weight management reduces downstream health costs — type 2 diabetes, cardiovascular disease, joint replacements — strengthens every year, and PBAC continues to engage with manufacturers. Most observers expect that when listing eventually comes, it will be restricted first: likely targeted at patients with higher BMIs plus established weight-related conditions.

No listing has been confirmed as at mid-2026. When that changes, we'll update this page the week it happens.

How to keep costs down while Wegovy stays off the PBS

• Bulk billed GP care. The consultations around your treatment — initial assessment, script renewals, dose reviews — can cost $0 for eligible Medicare card holders. Over a year that saves several hundred dollars compared with paying private consultation fees on top of the medicine.
• Compare pharmacies. Prices for the same pen genuinely differ between pharmacies — our price guide shows the spread.
• Don't rush up the doses. Higher doses cost more. Many patients respond well below the maximum dose; your GP can tailor titration to response rather than defaulting to the top dose.
• Check the alternatives. Different medications sit at very different price points — the full comparison is in our guide to every weight loss medication in Australia.

Frequently Asked Questions — Wegovy and the PBS

Is Wegovy covered by Medicare in Australia?

The medication itself is not covered by Medicare or the PBS for weight management. However, the GP consultations involved in assessment, prescribing and monitoring can be bulk billed through Medicare telehealth item numbers for eligible patients — so the medical care around Wegovy can be $0 even though the medicine is private.

Is Ozempic on the PBS instead?

Ozempic (semaglutide 1mg) is PBS-listed only for type 2 diabetes. When prescribed for weight management, it is also a private script. The complete PBS status table for every weight loss medication breaks this down.

How much does Wegovy cost per month without a subsidy?

Roughly $180–$320 per month depending on your dose and pharmacy. Lower titration doses sit at the cheaper end; the full 2.4mg maintenance dose sits at the top end.

When will Wegovy be on the PBS?

No date exists. PBAC has engaged with obesity medication submissions repeatedly, and most observers expect an eventual restricted listing, but nothing is confirmed as at mid-2026. Be wary of any site claiming a confirmed listing date.

Is Mounjaro on the PBS?

No — Mounjaro (tirzepatide) is in the same position. We cover it separately in our Mounjaro PBS guide.

Ready to talk through your options? Request a bulk billed telehealth consultation — no referral needed, and your GP will be upfront about exactly what your treatment would cost at the pharmacy.

PBS information current as at mid-2026 and subject to change — check pbs.gov.au for the latest schedule. This article is general information, not personal medical advice; always consult your doctor about your individual situation.